1. Home
  2. BOLD vs PXS Comparison

BOLD vs PXS Comparison

Compare BOLD & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • PXS
  • Stock Information
  • Founded
  • BOLD 2018
  • PXS 2015
  • Country
  • BOLD United States
  • PXS Greece
  • Employees
  • BOLD N/A
  • PXS N/A
  • Industry
  • BOLD
  • PXS Marine Transportation
  • Sector
  • BOLD
  • PXS Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • PXS Nasdaq
  • Market Cap
  • BOLD 30.3M
  • PXS 31.0M
  • IPO Year
  • BOLD 2024
  • PXS N/A
  • Fundamental
  • Price
  • BOLD $1.13
  • PXS $2.86
  • Analyst Decision
  • BOLD Buy
  • PXS Strong Buy
  • Analyst Count
  • BOLD 3
  • PXS 1
  • Target Price
  • BOLD $4.00
  • PXS $10.00
  • AVG Volume (30 Days)
  • BOLD 79.0K
  • PXS 28.4K
  • Earning Date
  • BOLD 05-09-2025
  • PXS 05-21-2025
  • Dividend Yield
  • BOLD N/A
  • PXS N/A
  • EPS Growth
  • BOLD N/A
  • PXS N/A
  • EPS
  • BOLD N/A
  • PXS 0.63
  • Revenue
  • BOLD N/A
  • PXS $49,342,000.00
  • Revenue This Year
  • BOLD N/A
  • PXS N/A
  • Revenue Next Year
  • BOLD N/A
  • PXS $34.15
  • P/E Ratio
  • BOLD N/A
  • PXS $4.56
  • Revenue Growth
  • BOLD N/A
  • PXS 8.07
  • 52 Week Low
  • BOLD $1.06
  • PXS $2.53
  • 52 Week High
  • BOLD $10.13
  • PXS $5.53
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • PXS 40.06
  • Support Level
  • BOLD N/A
  • PXS $2.72
  • Resistance Level
  • BOLD N/A
  • PXS $2.91
  • Average True Range (ATR)
  • BOLD 0.00
  • PXS 0.19
  • MACD
  • BOLD 0.00
  • PXS -0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • PXS 25.93

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.

Share on Social Networks: